Stage IVB Squamous Cell Carcinoma of the Oropharynx Completed Phase 1 / 2 Trials for Erlotinib (DB00530)

IndicationStatusPhase
DBCOND0029855 (Stage IVB Squamous Cell Carcinoma of the Oropharynx)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00063895Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and NeckTreatment